4,705
Views
88
CrossRef citations to date
0
Altmetric
Article

Evidence for the effects of yogurt on gut health and obesity

, , &
Pages 1569-1583 | Received 04 Nov 2013, Accepted 10 Jan 2014, Published online: 01 Mar 2017

References

  • Adolfsson, O., Meydani, S. N. and Russell, R. M. (2004). Yogurt and gut function. Am. J. Clin. Nutr. 80: 245–256.
  • Agostini, S., Goubern, M., Tondereau, V., Salvador-Cartier, C., Bezirard, V., Lévèque, M., et al. (2012). A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol. Motil. 24: 376–e172.
  • Al-Sadi, R., Boivin, M. and Ma, T. (2009). Mechanism of cytokine modulation of epithelial tight junction barrier. Front. Biosci. 14: 2765–2778.
  • Al-Sadi, R. M. and Ma, T. Y. (2007). IL-1β causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178: 4641–4649.
  • Amar, J., Burcelin, R., Ruidavets, J. B., Cani, P. D., Fauvel, J., Alessi, M. C., et al. (2008). Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 87: 1219–1223.
  • Anderson, J. W. and Gilliland, S. E. (1999). Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J. Am. Coll. Nutr. 18: 43–50.
  • Andreasen, A. S., Larsen, N., Pedersen-Skovsgaard, T., Berg, R. M. G., Mller, K., Svendsen, K. D., et al. (2010). Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br. J. Nutr. 104: 1831–1838.
  • Aneja, R. P. and Murthi, T. N. (1990). Conjugated linoleic acid contents of Indian curds and ghee. Indian J. Dairy Sci. 43: 231–238.
  • Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., et al. (1997). A clinical trial of the effects of dietary patterns on blood pressure. N. Engl. J. Med. 336: 1117–1124.
  • Bäckhed, F. (2009). Changes in intestinal microflora in obesity: Cause or consequence? J. Pediatr. Gastroenterol. Nutr. 48: S56–S57.
  • Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Gou, Y. K., Nagy, A., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 101: 15718–15723.
  • Bäckhed F., Manchester, J. K., Semenkovich, C. F. and Gordon, J. I. (2007). Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U. S. A. 104: 979–984.
  • Bashan, N., Dorfman, K., Tarnovscki, T., Harman-Boehm, I., Liberty, I. F., Her, M. B., et al. (2007). Mitogen-activated protein kinases, inhibitory-κB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology 148: 2955–2962.
  • Bluher, M., Engeli, S., Kloting, N., Berndt, J., Fasshauer, M., Batkai, S., et al. (2006). Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55: 3053–3060.
  • Boschi-Pinto, C., Velebit, L. and Shibuya, K. (2008). Estimating child mortality due to diarrhoea in developing countries. Bull. World Health Organ. 86: 710–717.
  • Brake, D. K., Smith, E. O. B., Mersmann, H., Smith, C. W. and Robker, R. L. (2006). ICAM-1 expression in adipose tissue: Effects of diet-induced obesity in mice. Am. J. Physiol. Cell Physiol. 291: C1232–C1239.
  • Brandtzaeg, P., Baekkevold, E. S., Farstad, I. N., Jahnsen, F. L., Johansen, F. E., Nilsen, E. M., et al. (1999). Regional specialization in the mucosal immune system: What happens in the microcompartments? Immunol. Today 20: 141–151.
  • Breslaw, E. S. and Kleyn, D. H. (1973). In vitro digestibility of protein in yogurt at various stages of processing. J. Food Sci. 38: 1016–1021.
  • Bruewer, M., Utech, M., Ivanov, A. I., Hopkins, A. M., Parkos, C. A. and Nusrat, A. (2005). Interferon-γ induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 19: 923–933.
  • Brun, P., Castagliuolo, I., Di Leo, V., Buda, A., Pinzani, M., Palù, G., et al. (2007). Increased intestinal permeability in obese mice: New evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G518–G525.
  • Buttriss, J. (1997). Nutritional properties of fermented milk products. Int. J. Dairy Technol. 50: 21–27.
  • Caballero-Franco, C., Keller, K., De Simone, C. and Chadee, K. (2007). The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G315–G322.
  • Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., et al. (2005). Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat. Med. 11: 183–190.
  • Calle, E. E., Rodriguez, C., Walker-Thurmond, K. and Thun, M. J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. N. Engl. J. Med. 348: 1625–1638.
  • Cameron, H. L. and Perdue, M. H. (2005). Stress impairs murine intestinal barrier function: Improvement by glucagon-like peptide-2. J. Pharmacol. Exp. Ther. 314: 214–220.
  • Cameron, H. L., Yang, P. C. and Perdue, M. H. (2003). Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G905–G912.
  • Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761–1772.
  • Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470–1481.
  • Chapelot, D. and Payen, F. (2010). Comparison of the effects of a liquid yogurt and chocolate bars on satiety: A multidimensional approach. Br. J. Nutr. 103: 760–767.
  • Chaves, S., Perdigon, G. and De Moreno De Leblanc, A. (2011). Yoghurt consumption regulates the immune cells implicated in acute intestinal inflammation and prevents the recurrence of the inflammatory process in a mouse model. J. Food Prot. 74: 801–811.
  • Chen, R. M., Wu, J. J., Lee, S. C., Huang, A. H. and Wu, H. M. (1999). Increase of intestinal Bifidobacterium and suppression of coliform bacteria with short-term yogurt ingestion. J. Dairy Sci. 82: 2308–2314.
  • Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo Jr, J. L., et al. (2003). The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA. 289: 2560–2572.
  • Claes, I. J. J., De Keersmaecker, S. C. J., Vanderleyden, J. and Lebeer, S. (2011). Lessons from probiotic-host interaction studies in murine models of experimental colitis. Mol. Nutr. Food Res. 55: 1441–1453.
  • Clark, E., Hoare, C., Tanianis-Hughes, J., Carlson, G. L. and Warhurst, G. (2005). Interferon γ induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 128: 1258–1267.
  • Cluny, N. L., Reimer, R. A. and Sharkey, K. A. (2012). Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis. Brain Behav. Immun. 26: 691–698.
  • Cohen, A. B., Lee, D., Long, M. D., Kappelman, M. D., Martin, C. F., Sandler, R. S., et al. (2013). Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig. Dis. Sci. 58: 1322–1328.
  • Corthésy, B. (2007). Roundtrip ticket for secretory IgA: Role in mucosal homeostasis? J. Immunol. 178: 27–32.
  • Côté, M., Matias, I., Lemieux, I., Petrosino, S., Alméras, N., Després, J. P., et al. (2007). Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int. J. Obes (Lond). 31: 692–699.
  • Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., et al. (2007). Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292: E740–E747.
  • Crittenden, R. G., Martinez, N. R. and Playne, M. J. (2003). Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int. J. Food Microbiol. 80: 217–222.
  • Curat, C. A., Wegner, V., Sengenès, C., Miranville, A., Tonus, C., Busse, R., et al. (2006). Macrophages in human visceral adipose tissue: Increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49: 744–747.
  • De Paula, R. B., Da Silva, A. A. and Hall, J. E. (2004). Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration. Hypertension 43: 41–47.
  • De Simone, C., Bianchi Salvadori, B. and Negri, R. (1986). The adjuvant effect of yogurt on production of gamma-interferon by Con A-stimulated human peripheral blood lymphocytes. Nutr. Rep. Int. 33: 419–433.
  • De Souza, C. T., Araujo, E. P., Bordin, S., Ashimine, R., Zollner, R. L., Boschero, A. C., et al. (2005). Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146: 4192–4199.
  • Del Campo, R., Bravo, D., Cantón, R., Ruiz-Garbajosa, P., García-Albiach, R., Montesi-Libois, A., et al. (2005). Scarce evidence of yogurt lactic acid bacteria in human feces after daily yogurt consumption by healthy volunteers. Appl. Environ. Microbiol. 71: 547–549.
  • Desobry-Banon, S., Vetier, N. and Hardy, J. (1999). Health benefits of yogurt consumption. A review. Int. J. Food Prop. 2: 1–12.
  • Dharmani, P., Srivastava, V., Kissoon-Singh, V. and Chadee, K. (2009). Role of intestinal mucins in innate host defense mechanisms against pathogens. J. Innate Immun. 1: 123–135.
  • Dougkas, A., Minihane, A. M., Givens, D. I., Reynolds, C. K. and Yaqoob, P. (2012). Differential effects of dairy snacks on appetite, but not overall energy intake. Br. J. Nutr. 108: 2274–2285.
  • Douglas, S. M., Ortinau, L. C., Hoertel, H. A. and Leidy, H. J. (2013). Low, moderate, or high protein yogurt snacks on appetite control and subsequent eating in healthy women. Appetite 60: 117–122.
  • Dunlap, B. S., Yu, H. and Elitsur, Y. (2009). The probiotic content of commercial yogurts in West Virginia. Clin. Pediatr. (Phila). 48: 522–527.
  • Ebringer, L., Ferenčík, M. and Krajčovič, J. (2008). Beneficial health effects of milk and fermented dairy products - Review. Folia Microbiol. 53: 378–394.
  • Egan, B. M., Zhao, Y. and Axon, R. N. (2010). US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 303: 2043–2050.
  • Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., et al. (2007). Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56: 2356–2370.
  • Elli, M., Callegari, M. L., Ferrari, S., Bessi, E., Cattivelli, D., Soldi, S., et al. (2006). Survival of yogurt bacteria in the human gut. Appl. Environ. Microbiol. 72: 5113–5117.
  • Erridge, C., Attina, T., Spickett, C. M. and Webb, D. J. (2007). A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86: 1286–1292.
  • Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., et al. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U. S. A. 110: 9066–9071.
  • Fabian, E. and Elmadfa, I. (2006). Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann. Nutr. Metab. 50: 387–393.
  • Flegal, K. M., Carroll, M. D., Ogden, C. L. and Curtin, L. R. (2010). Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 303: 235–241.
  • Gaudichon, C., Roos, N., Mahe, S., Sick, H., Bouley, C. and Tome, D. (1994). Gastric emptying regulates the kinetics of nitrogen absorption from 15N- labeled milk and 15N-labeled yogurt in miniature pigs. J. Nutr. 124: 1970–1977.
  • German, J. B., Gibson, R. A., Krauss, R. M., Nestel, P., Lamarche, B., Van Staveren, W. A., et al. (2009). A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur. J. Nutr. 48: 191–203.
  • Ghanim, H., Sia, C. L., Upadhyay, M., Korzeniewski, K., Viswanathan, P., Abuaysheh, S., et al. (2010). Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression. Am. J. Clin. Nutr. 91: 940–949.
  • Gill, H. S., Rutherfurd, K. J., Prasad, J. and Gopal, P. K. (2000). Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 83: 167–176.
  • Gilliland, S. E. and Speck, M. L. (1977). Instability of Lactobacillus acidophilus in Yogurt. J. Dairy Sci. 60: 1394–1398.
  • Gobbato, N., Rachid, M. and Perdigón, G. (2008). Anti-inflammatory effect of yoghurt in an experimental inflammatory bowel disease in mouse. J. Dairy Res. 75: 497–504.
  • Gonzalez-Quintela, A., Alende, R., Gude, F., Campos, J., Rey, J., Meijide, L. M., et al. (2008). Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol 151: 42–50.
  • Goodfriend, T. L. and Calhoun, D. A. (2004). Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy. Hypertension 43: 518–524.
  • Gorbach, S. L. (1990). Lactic acid bacteria and human health. Ann. Med. 22: 37–41.
  • Gregor, M. F. and Hotamisligil, G. S. (2011). Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29: 415–445.
  • Grundy, S. M. (2007). Metabolic syndrome: A multiplex cardiovascular risk factor. J. Clin. Endocrinol. Metab. 92: 399–404.
  • Guarner, F., Perdigon, G., Corthier, G., Salminen, S., Koletzko, B. and Morelli, L. (2005). Should yoghurt cultures be considered probiotic? Br. J. Nutr. 93: 783–786.
  • Gueguen, L. and Pointillart, A. (2000). The bioavailability of dietary calcium. J. Am. Coll. Nutr. 19: 119S–136S.
  • Gummesson, A., Carlsson, L. M. S., Storlien, L. H., Bäckhed, F., Lundin, P., Löfgren, L., et al. (2011). Intestinal permeability is associated with visceral adiposity in healthy women. Obesity 19: 2280–2282.
  • Halpern, G. M., Vruwink, K. G., Van De Water, J., Keen, C. L. and Gershwin, M. E. (1991). Influence of long-term yoghurt consumption in young adults. Int. J. Immunother. 7: 205–210.
  • Hartsock, A. and Nelson, W. J. (2008). Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton. Biochim. Biophys. Acta 1778: 660–669.
  • Haslam, D. W. and James, W. P. T. (2005). Obesity Lancet 366: 1197–1209.
  • Hedin, C., Whelan, K. and Lindsay, J. O. (2007). Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: A review of clinical trials. Proc. Nutr. Soc. 66: 307–315.
  • Herder, C., Schneitler, S., Rathmann, W., Haastert, B., Schneitler, H., Winkler, H., et al. (2007). Low-grade inflammation, obesity, and insulin resistance in adolescents. J. Clin. Endocrinol. Metab. 92: 4569–4574.
  • Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., et al. (2002). A central, role for JNK in obesity and insulin resistance. Nature 420: 333–336.
  • Hodin, C. M., Verdam, F. J., Grootjans, J., Rensen, S. S., Verheyen, F. K., Dejong, C. H. C., et al. (2011). Reduced Paneth cell antimicrobial protein levels correlate with activation of the unfolded protein response in the gut of obese individuals. J. Pathol. 225: 276–284.
  • Holes-Lewis, K. A., Malcolm, R. and O'Neil, P. M. (2013). Pharmacotherapy of obesity: Clinical treatments and considerations. Am. J. Med. Sci. 345: 284–288.
  • Hossain, P., Kawar, B. and El Nahas, M. (2007). Obesity and diabetes in the developing world - A growing challenge. N. Engl. J. Med. 356: 213–215.
  • Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature 444: 860–867.
  • Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. and Spiegelman, B. M. (1995). Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95: 2409–2415.
  • Howe, K. L., Reardon, C., Wang, A., Nazli, A. and McKay, D. M. (2005). Transforming growth factor-β regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am. J. Pathol. 167: 1587–1597.
  • Huth, P. J. and Park, K. M. (2012). Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence. Adv. Nutr. 3: 266–285.
  • Irvine, S. L., Hummelen, R., Hekmat, S., W. N. Looman, C., Habbema, J. D. F. and Reid, G. (2010). Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J. Clin. Gastroenterol. 44: e201–e205.
  • Isolauri, E., Kaila, M., Arvola, T., Majamaa, H., Rantala, I., Virtanen, E., et al. (1993). Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr. Res. 33: 548–553.
  • Jijon, H., Backer, J., Diaz, H., Yeung, H., Thiel, D., McKaigney, C., et al. (2004). DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126: 1358–1373.
  • Jonkers, D., Penders, J., Masclee, A. and Pierik, M. (2012). Probiotics in the management of inflammatory bowel disease: A systematic review of intervention studies in adult patients. Drugs 72: 803–823.
  • Jouet, P., Coffin, B. and Sabate, J. M. (2011). Small intestinal bacterial overgrowth in patients with morbid obesity. Dig. Dis. Sci. 56: 615–616.
  • Kabeerdoss, J., Shobana Devi, R., Regina Mary, R., Prabhavathi, D., Vidya, R., Mechenro, J., et al. (2011). Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers. Nutr. J. 10:138.
  • Kahn, S. E., Hull, R. L. and Utzschneider, K. M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840–846.
  • Kale-Pradhan, P. B., Jassal, H. K. and Wilhelm, S. M. (2010). Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: A meta-analysis. Pharmacotherapy 30: 119–126.
  • Kastarinen, M. J., Nissinen, A. M., Vartiainen, E. A., Jousilahti, P. J., Korhonen, H. J., Puska, P. M., et al. (2000). Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. J. Hypertens. 18: 255–262.
  • Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., et al. (2004). Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment. Pharmacol. Ther. 20: 1133–1141.
  • Kemna, E., Pickkers, P., Nemeth, E., Van Der Hoeven, H. and Swinkels, D. (2005). Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106: 1864–1866.
  • Kern, P. A., Ranganathan, S., Li, C., Wood, L. and Ranganathan, G. (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280: E745–E751.
  • Kießling, G., Schneider, J. and Jahreis, G. (2002). Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur. J. Clin. Nutr. 56: 843–849.
  • Kim, C. S., Park, H. S., Kawada, T., Kim, J. H., Lim, D., Hubbard, N. E., et al. (2006). Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes (Lond). 30: 1347–1355.
  • Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., et al. (2007). Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100: 1589–1596.
  • Kim, Y. S. and Ho, S. B. (2010). Intestinal goblet cells and mucins in health and disease: Recent insights and progress. Curr. Gastroenterol. Rep. 12: 319–330.
  • Kinugasa, T., Sakaguchi, T., Gu, X. and Reinecker, H. (2000). Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118: 1001–1011.
  • Kolars, J. C., Levitt, M. D., Aouji, M. and Savaiano, D. A. (1984). Yogurt - an autodigesting source of lactose. N. Engl. J. Med. 310: 1–3.
  • Labonté, M. E., Couture, P., Richard, C., Desroches, S. and Lamarche, B. (2013). Impact of dairy products on biomarkers of inflammation: A systematic review of randomized controlled nutritional intervention studies in overweight and obese adults. Am. J. Clin. Nutr. 97: 706–717.
  • Larsson, S. C., Andersson, S. O., Johansson, J. E. and Wolk, A. (2008). Cultured milk, yogurt, and dairy intake in relation to bladder cancer risk in a prospective study of Swedish women and men. Am. J. Clin. Nutr. 88: 1083–1087.
  • Larsson, S. C. and Wolk, A. (2007). Obesity and colon and rectal cancer risk: A meta-analysis of prospective studies. Am. J. Clin. Nutr. 86: 556–565.
  • Laugerette, F., Vors, C., Géloën, A., Chauvin, M. A., Soulage, C., Lambert-Porcheron, S., et al. (2011). Emulsified lipids increase endotoxemia: Possible role in early postprandial low-grade inflammation. J. Nutr. Biochem. 22: 53–59.
  • Lavie, C. J., Milani, R. V. and Ventura, H. O. (2009). Obesity and cardiovascular disease. Risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 53: 1925–1932.
  • Leal, E. C., Martins, J., Voabil, P., Liberal, J., Chiavaroli, C., Bauer, J., et al. (2010). Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes 59: 2637–2645.
  • Lewington, S., Clarke, R., Qizilbash, N., Peto, R. and Collins, R. (2002). Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903–1913.
  • Ley, R. E., Turnbaugh, P. J., Klein, S. and Gordon, J. I. (2006). Microbial ecology: Human gut microbes associated with obesity. Nature 444: 1022–1023.
  • Li, Q., Zhang, Q., Wang, M., Zhao, S., Ma, J., Luo, N., et al. (2008). Interferon-γ and tumor necrosis factor-α disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin. Immunol. 126: 67–80.
  • Link-Amster, H., Rochat, F., Saudan, K. Y., Mignot, O. and Aeschlimann, J. M. (1994). Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol. 10: 55–63.
  • Lomer, M. C. E., Parkes, G. C. and Sanderson, J. D. (2008). Review article: Lactose intolerance in clinical practice - Myths and realities. Aliment. Pharmacol. Ther. 27: 93–103.
  • Lorea Baroja, M., Kirjavainen, P. V., Hekmat, S. and Reid, G. (2007). Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin. Exp. Immunol. 149: 470–479.
  • Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095–2128.
  • Mack, D. R., Michail, S., Wei, S., McDougall, L. and Hollingsworth, M. A. (1999). Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 276: G941–G950.
  • Macpherson, A. J. and Uhr, T. (2004). Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303: 1662–1665.
  • Madsen, K. L., Lewis, S. A., Tavernini, M. M., Hibbard, J. and Fedorak, R. N. (1997). Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology 113: 151–159.
  • Manco, M., Putignani, L. and Bottazzo, G. F. (2010). Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr. Rev. 31: 817–844.
  • Mankertz, J., Tavalali, S., Schmitz, H., Mankertz, A., Riecken, E. O., Fromm, M., et al. (2000). Expression from the human occludin promoter is affected by tumor necrosis factor α and interferon γ. J. Cell Sci. 113: 2085–2090.
  • Marconi, E., Messia, M. C., Amine, A., Moscone, D., Vernazza, F., Stocchi, F., et al. (2004). Heat-treated milk differentiation by a sensitive lactulose assay. Food Chem. 84: 447–450.
  • Margolis, K. L., Wei, F., de Boer, I. H., Howard, B. V., Liu, S., Manson, J. E., et al. (2011). A diet high in low-fat dairy products lowers diabetes risk in postmenopausal women. J. Nutr. 141: 1969–1974.
  • Maroof, H., Hassan, Z. M., Mobarez, A. M. and Mohamadabadi, M. A. (2012). Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J. Clin. Immunol. 32: 1353–1359.
  • Martínez-Maqueda, D., Miralles, B., De Pascual-Teresa, S., Reverón, I., Muñoz, R. and Recio, I. (2012). Food-derived peptides stimulate mucin secretion and gene expression in intestinal cells. J. Agric. Food. Chem. 60: 8600–8605.
  • Martini, M. C., Lerebours, E. C., Lin, W. J., Harlander, S. K., Berrada, N. M., Antoine, J. M., et al. (1991). Strains and species of lactic acid bacteria in fermented milks (yogurts): Effect on in vivo lactose digestion. Am. J. Clin. Nutr. 54: 1041–1046.
  • Massiéra, F., Bloch-Faure, M., Ceiler, D., Murakami, K., Fukamizu, A., Gasc, J. M., et al. (2001). Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 15: 2727–2729.
  • Mater, D. D. G., Bretigny, L., Firmesse, O., Flores, M. J., Mogenet, A., Bresson, J. L., et al. (2005). Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. FEMS Microbiol. Lett. 250: 185–187.
  • Mathieu, P., Lemieux, I. and Després, J. P. (2010). Obesity, inflammation, and cardiovascular risk. Clin. Pharmacol. Ther. 87: 407–416.
  • Matsumoto, M., Aranami, A., Ishige, A., Watanabe, K. and Benno, Y. (2007). LKM512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis. Clin. Exp. Allergy 37: 358–370.
  • Matsumoto, M., Ohishi, H. and Benno, Y. (2001). Impact of LKM512 yogurt on improvement of intestinal environment of the elderly. FEMS Immunol. Med. Microbiol. 31: 181–186.
  • Mauras, N., DelGiorno, C., Kollman, C., Bird, K., Morgan, M., Sweeten, S., et al. (2010). Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J. Clin. Endocrinol. Metab. 95: 1060–1068.
  • McNulty, N. P., Yatsunenko, T., Hsiao, A., Faith, J. J., Muegge, B. D., Goodman, A. L., et al. (2011). The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 3: 106ra106.
  • Miele, E., Pascarella, F., Giannetti, E., Quaglietta, L., Baldassano, R. N. and Staiano, A. (2009). Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am. J. Gastroenterol. 104: 437–443.
  • Moghaddam, A. A., Woodward, M. and Huxley, R. (2007). Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol. Biomarkers Prev. 16: 2533–2547.
  • Morikawa, K., Kondo, I., Kanamaru, Y. and Nagaoka, S. (2007). A novel regulatory pathway for cholesterol degradation via lactostatin. Biochem. Biophys. Res. Commun. 352: 697–702.
  • Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., et al. (2010). The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 6.
  • Muoio, D. M. and Newgard, C. B. (2008). Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9: 193–205.
  • Nakamura, T., Mizutani, J., Sasaki, K., Yamamoto, N. and Takazawa, K. (2009). Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: A preliminary study. J. Med. Food 12: 1221–1226.
  • National-Yogurt-Association (2008). Live and Active Culture Yogurt Seal Program. McLean, VA.
  • Nicklas, T. A., Qu, H., Hughes, S. O., He, M., Wagner, S. E., Foushee, H. R., et al. (2011). Self-perceived lactose intolerance results in lower intakes of calcium and dairy foods and is associated with hypertension and diabetes in adults. Am. J. Clin. Nutr. 94: 191–198.
  • O'Hara, A. M. and Shanahan, F. (2006). The gut flora as a forgotten organ. EMBO Rep. 7: 688–693.
  • O'Sullivan, M. G., Thornton, G., O'Sullivan, G. C. and Collins, J. K. (1992). Probiotic bacteria: myth or reality? Trends Food Sci. Tech. 3: 309–314.
  • Ohmura, K., Ishimori, N., Ohmura, Y., Tokuhara, S., Nozawa, A., Horii, S., et al. (2010). Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler. Thromb. Vasc. Biol. 30: 193–199.
  • Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., et al. (2001). The extra domain A of fibronectin activates toll-like receptor 4. J. Biol. Chem. 276: 10229–10233.
  • Ortakci, F. and Sert, S. (2012). Stability of free and encapsulated Lactobacillus acidophilus ATCC 4356 in yogurt and in an artificial human gastric digestion system. J. Dairy Sci. 95: 6918–6925.
  • Oshima, T., Laroux, F. S., Coe, L. L., Morise, Z., Kawachi, S., Bauer, P., et al. (2001). Interferon-γ and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc. Res. 61: 130–143.
  • Pala, V., Sieri, S., Berrino, F., Vineis, P., Sacerdote, C., Palli, D., et al. (2011). Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. Int. J. Cancer 129: 2712–2719.
  • Panagiotakos, D. B., Pitsavos, C., Yannakoulia, M., Chrysohoou, C. and Stefanadis, C. (2005). The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 183: 308–315.
  • Park, B. S., Song, D. H., Kim, H. M., Choi, B. S., Lee, H. and Lee, J. O. (2009). The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191–1195.
  • Park, Y., Albright, K. J., Liu, W., Storkson, J. M., Cook, M. E. and Pariza, M. W. (1997). Effect of conjugated linoleic acid on body composition in mice. Lipids 32: 853–858.
  • Parvez, S., Malik, K. A., Ah Kang, S. and Kim, H. Y. (2006). Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol. 100: 1171–1185.
  • Peeters, A., Barendregt, J. J., Willekens, F., Mackenbach, J. P., Al Mamun, A., Bonneux, L., et al. (2003). Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann. Intern. Med. 138: 24–32.
  • Perdigon, G., Alvarez, S., Rachid, M., Agüero, G. and Gobbato, N. (1995). Immune system stimulation by probiotics. J. Dairy Sci. 78: 1597–1606.
  • Pineiro, M. and Embarek, B. (2002). Guidelines for the Evaluation of Probiotics in Food. London Ontario, Canada, FAO/WHO.
  • Porter, E. M., Bevins, C. L., Ghosh, D. and Ganz, T. (2002). The multifaceted Paneth cell. Cell Mol. Life Sci. 59: 156–170.
  • Pugin, J., Heumann, D., Tomaszi, A., Kravchenko, V. V., Akamatsu, Y., Nishijima, M., et al. (1994). CD14 is a pattern recognition receptor. Immunity 1: 509–516.
  • Puri, P., Rattan, A., Bijlani, R. L., Mahapatra, S. C. and Nath, I. (1996). Splenic and intestinal lymphocyte proliferation response in mice fed milk or yogurt and challenged with Salmonella typhimurium. Int. J. Food Sci. Nutr. 47: 391–398.
  • Raetz, C. R. H. and Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71: 635–700.
  • Rahmouni, K., Correia, M. L. G., Haynes, W. G. and Mark, A. L. (2005). Obesity-associated hypertension: New insights into mechanisms. Hypertension 45: 9–14.
  • Rallabhandi, P., Bell, J., Boukhvalova, M. S., Medvedev, A., Lorenz, E., Arditi, M., et al. (2006). Analysis of TLR4 polymorphic variants: New insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J. Immunol. 177: 322–332.
  • Ralston, R. A., Lee, J. H., Truby, H., Palermo, C. E. and Walker, K. Z. (2012). A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J. Hum. Hypertens. 26: 3–13.
  • Recker, R. R., Bammi, A., Barger-Lux, M. and Heaney, R. P. (1988). Calcium absorbability from milk products, an imitation milk and calcium carbonate. Am. J. Clin. Nutr. 47: 93–95.
  • Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E. and Bull, D. (2007). Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ. 335: 1134–1139.
  • Rombaut, R., Camp, J. V. and Dewettinck, K. (2005). Analysis of phospho- and sphingolipids in dairy products by a new HPLC method. J. Dairy Sci. 88: 482–488.
  • Saavedra, J. M., Bauman, N. A., Oung, I., Perman, J. A. and Yolken, R. H. (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344: 1046–1049.
  • Sadrzadeh-Yeganeh, H., Elmadfa, I., Djazayery, A., Jalali, M., Heshmat, R. and Chamary, M. (2010). The effects of probiotic and conventional yoghurt on lipid profile in women. Br. J. Nutr. 103: 1778–1783.
  • Sakamoto, I., Igarashi, M., Kimura, K., Takagi, A., Miwa, T. and Koga, Y. (2001). Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother. 47: 709–710.
  • Salzman, N. H., Underwood, M. A. and Bevins, C. L. (2007). Paneth cells, defensins, and the commensal microbiota: A hypothesis on intimate interplay at the intestinal mucosa. Semin. Immunol. 19: 70–83.
  • Scaldaferri, F., Pizzoferrato, M., Gerardi, V., Lopetuso, L. and Gasbarrini, A. (2012). The gut barrier: New acquisitions and therapeutic approaches. J. Clin. Gastroenterol. 46: S12–S17.
  • Schaafsma, G., Meuling, W. J. A., Van Dokkum, W. and Bouley, C. (1998). Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur. J. Clin. Nutr. 52: 436–440.
  • Scharl, M., Geisel, S., Vavricka, S. R. and Rogler, G. (2010). Dying in yoghurt: The number of living bacteria in probiotic yoghurt decreases under exposure to room temperature. Digestion 83: 13–17.
  • Schiffrin, E. J., Brassart, D., Servin, A. L., Rochat, F. and Donnet-Hughes, A. (1997). Immune modulation of blood leukocytes in humans by lactic acid bacteria: Criteria for strain selection. Am. J. Clin. Nutr. 66: 515S–520S.
  • Schiffrin, E. J., Parlesak, A., Bode, C., Bode, J. C., van't Hof, M. A., Grathwohl, D., et al. (2009). Probiotic yogurt in the elderly with intestinal bacterial overgrowth: Endotoxaemia and innate immune functions. Br. J. Nutr. 101: 961–966.
  • Schillinger, U. (1999). Isolation and identification of lactobacilli from novel-type probiotic and mild yoghurts and their stability during refrigerated storage. Int. J. Food Microbiol. 47: 79–87.
  • Schlee, M., Harder, J., Köten, B., Stange, E. F., Wehkamp, J. and Fellermann, K. (2008). Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2. Clin. Exp. Immunol. 151: 528–535.
  • Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F. and Fellermann, K. (2007). Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75: 2399–2407.
  • Schmitz, H., Fromm, M., Bentzel, C. J., Scholz, P., Detjen, K., Mankertz, J., et al. (1999). Tumor necrosis factor-alpha (TNFα) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell Sci. 112: 137–146.
  • Shah, N. P. (2007). Functional cultures and health benefits. Int. Dairy J. 17: 1262–1277.
  • Shahani, K. M. and Chandan, R. C. (1979). Nutritional and healthful aspects of cultured and culture-containing dairy foods. J. Dairy Sci. 62: 1685–1694.
  • Shaw, J. E., Sicree, R. A. and Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87: 4–14.
  • Sheikh, M. S., Santa Ana, C. A., Nicar, M. J., Schiller, L. R. and Fordtran, J. S. (1987). Gastrointestinal absorption of calcium from milk and calcium salts. N. Engl. J. Med. 317: 532–536.
  • Shoelson, S. E., Lee, J. and Goldfine, A. B. (2006). Inflammation and insulin resistance. J. Clin. Invest. 116: 1793–1801.
  • Shulman, G. I. (2000). Cellular mechanisms of insulin resistance. J. Clin. Invest. 106: 171–176.
  • Sluijs, I., Forouhi, N. G., Beulens, J. W. J., Van Der Schouw, Y. T., Agnoli, C., Arriola, L., et al. (2012). The amount and type of dairy product intake and incident type 2 diabetes: Results from the EPIC-InterAct Study. Am. J. Clin. Nutr. 96: 382–390.
  • Smith, T. M., Kolars, J. C., Savaiano, D. A. and Levitt, M. D. (1985). Absorption of calcium from milk and yogurt. Am. J. Clin. Nutr. 42: 1197–1200.
  • Soedamah-Muthu, S. S., Verberne, L. D. M., Ding, E. L., Engberink, M. F. and Geleijnse, J. M. (2012). Dairy consumption and incidence of hypertension: A dose-response meta-analysis of prospective cohort studies. Hypertension 60: 1131–1137.
  • Solinas, G. and Karin, M. (2010). JNK1 and IKKβ: Molecular links between obesity and metabolic dysfunction. FASEB J. 24: 2596–2611.
  • Sommansson, A., Nylander, O. and Sjöblom, M. (2013). Melatonin decreases duodenal epithelial paracellular permeability via a nicotinic receptor-dependent pathway in rats in vivo. J. Pineal Res. 54: 282–291.
  • Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., et al. (2009). The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin. Gastroenterol. Hepatol. 7: 1202–1209.e1201.
  • Stoll, L. L., Denning, G. M., Li, W. G., Rice, J. B., Harrelson, A. L., Romig, S. A., et al. (2004). Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: Expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J. Immunol. 173: 1336–1343.
  • Stuart, R. O., Sun, A., Panichas, M., Hebert, S. C., Brenner, B. M. and Nigam, S. K. (1994). Critical role for intracellular calcium in tight junction biogenesis. J. Cell Physiol. 159: 423–433.
  • Struijk, E. A., Heraclides, A., Witte, D. R., Soedamah-Muthu, S. S., Geleijnse, J. M., Toft, U., et al. (2013). Dairy product intake in relation to glucose regulation indices and risk of type 2 diabetes. Nutr. Metab. Cardiovasc. Dis 23: 822–828.
  • Sun, L., Yu, Z., Ye, X., Zou, S., Li, H., Yu, D., et al. (2010). A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33: 1925–1932.
  • Teixeira, T. F. S., Souza, N. C. S., Chiarello, P. G., Franceschini, S. C. C., Bressan, J., Ferreira, C. L. L. F., et al. (2012). Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin. Nutr. 31: 735–740.
  • Tenenbaum, A. and Fisman, E. Z. (2012). Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction. Cardiovasc. Diabetol. 11:125.
  • Thomas, A. P., Dunn, T. N., Drayton, J. B., Oort, P. J. and Adams, S. H. (2012). A high calcium diet containing nonfat dry milk reduces weight gain and associated adipose tissue inflammation in diet-induced obese mice when compared to high calcium alone. Nutr. Metab. (Lond). 9:3.
  • Tilg, H. and Kaser, A. (2011). Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121: 2126–2132.
  • Tong, X., Dong, J. Y., Wu, Z. W., Li, W. and Qin, L. Q. (2011). Dairy consumption and risk of type 2 diabetes mellitus: A meta-analysis of cohort studies. Eur. J. Clin. Nutr. 65: 1027–1031.
  • Tsuchiya, A., Almiron-Roig, E., Lluch, A., Guyonnet, D. and Drewnowski, A. (2006). Higher satiety ratings following yogurt consumption relative to fruit drink or dairy fruit drink. J. Am. Diet. Assoc. 106: 550–557.
  • Tsukita, S., Furuse, M. and Itoh, M. (2001). Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2: 285–293.
  • Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R. and Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027–1031.
  • Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9: 799–809.
  • Van Bossuyt, H., De Zanger, R. B. and Wisse, E. (1988). Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J. Hepatol. 7: 325–337.
  • Van Kruijsdijk, R. C. M., Van Der Wall, E. and Visseren, F. L. J. (2009). Obesity and cancer: The role of dysfunctional adipose tissue. Cancer Epidemiol. Biomarkers Prev. 18: 2569–2578.
  • Van Meijl, L. E. C., Vrolix, R. and Mensink, R. P. (2008). Dairy product consumption and the metabolic syndrome. Nutr. Res. Rev. 21: 148–157.
  • Van Niel, C. W., Feudtner, C., Garrison, M. M. and Christakis, D. A. (2002). Lactobacillus therapy for acute infectious diarrhea in children: A meta-analysis. Pediatrics 109: 678–684.
  • Vélez, M. P., Hermans, K., Verhoeven, T. L. A., Lebeer, S. E., Vanderleyden, J. and De Keersmaecker, S. C. J. (2007). Identification and characterization of starter lactic acid bacteria and probiotics from Columbian dairy products. J. Appl. Microbiol. 103: 666–674.
  • Wadden, T. A., Webb, V. L., Moran, C. H. and Bailer, B. A. (2012). Lifestyle modification for obesity: New developments in diet, physical activity, and behavior therapy. Circulation 125: 1157–1170.
  • Warensjö, E., Jansson, J. H., Cederholm, T., Boman, K., Eliasson, M., Hallmans, G., et al. (2010). Biomarkers of milk fat and the risk of myocardial infarction in men and women: A prospective, matched case-control study. Am. J. Clin. Nutr. 92: 194–202.
  • Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L. and Ferrante Jr, A. W. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112: 1796–1808.
  • Whigham, L. D., Cook, M. E. and Atkinson, R. L. (2000). Conjugated linoleic acid: Implications for human health. Pharmacol. Res. 42: 503–510.
  • Woof, J. M. and Ken, M. A. (2006). The function of immunoglobulin A in immunity. J. Pathol. 208: 270–282.
  • Wu, H., Ghosh, S., Perrard, X. D., Feng, L., Garcia, G. E., Perrard, J. L., et al. (2007). T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115: 1029–1038.
  • Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., et al. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821–1830.
  • Yang, H., Kiristioglu, I., Fan, Y., Forbush, B., Bishop, D. K., Antony, P. A., et al. (2002). Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition. Ann. Surg. 236: 226–234.
  • Yang, R., Han, X., Uchiyama, T., Watkins, S. K., Yaguchi, A., Delude, R. L., et al. (2003). IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G621–G629.
  • Yang, Y. J. and Sheu, B. S. (2012). Probiotics-containing yogurts suppress helicobacter pylori load and modify immune response and intestinal microbiota in the helicobacter pylori-infected children. Helicobacter 17: 297–304.
  • Youakim, A. and Ahdieh, M. (1999). Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am. J. Physiol. Gastrointest. Liver Physiol. 276: G1279–G1288.
  • Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415: 389–395.
  • Zemel, M. B., Shi, H., Greer, B., Dirienzo, D. and Zemel, P. C. (2000). Regulation of adiposity by dietary calcium. FASEB J. 14: 1132–1138.
  • Zemel, M. B., Thompson, W., Milstead, A., Morris, K. and Campbell, P. (2004). Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes. Res. 12: 582–590.
  • Zhao, Y., Martin, B. R. and Weaver, C. M. (2005). Calcium bioavailability of calcium carbonate fortified soymilk is equivalent to cow's milk in young women. J. Nutr. 135: 2379–2382.
  • Zsivkovits, M., Fekadu, K., Sontag, G., Nabinger, U., Huber, W. W., Kundi, M., et al. (2003). Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains. Carcinogenesis 24: 1913–1918.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.